Cooperating organisations

European Action Against Rare Cancers is a partnership between many organisations.

European Action Against Rare Cancers is a joint initiative based on a partnership between the European Society for Medical Oncology (ESMO), the European Organisation for Rare Diseases (Eurordis), the European Cancer Patient Coalition (ECPC), Conticanet, the Association of European Cancer Leagues (ECL), the Chronic Myeloid Leukaemia Support Group, the International Brain Tumour Alliance (IBTA), Orphanet, Chronic Myeloid Leukaemia Advocates Network, Fondazione IRCCS Istituto Nazionale dei Tumori, and the European Institute of Oncology (EIO), as well as Novartis Oncology as the initiating sponsor. The campaign is moreover supported by seven other corporate supporters.

The corporating organisations are all represented in the Campaign Organisation Committee where their representatives work together as equal partners. Moreover, a Campaign Steering Committee provides guidance and oversees the overall scope of the campaign.

The collaboration began in 2008 in relation to the organisation of the conference "Rare Tumours in Europe: Challenges and Solutions". Since then, the organisations have continued to work together and more organisations have joined.

	European Society for Medical Oncology
	European Organisation for Rare Diseases
	European Cancer Patient Coalition
	Conticanet
	Association of European Cancer Leagues (ECL)
	Chronic Myeloid Leukaemia Support Group
	International Brain Tumour Alliance
	Orphanet
	CML Advocates Network
	Fondazione IRCCS Istituto Nazionale dei Tumori
	European Institute of Oncology
	Novartis Oncology

Would your organisation like to become involved in this campaign? Please contact us.

2. Call to Action